The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

It's officially that time of the year: our skin is itchy, scaly, and more closely resembles a lizard than a dewy, glazed donut. You likely have a dozen barrier-repairing lip balms and thick hand ...

Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after 2 prior therapy failures. The FDA has granted approval to axatilimab-csfr ...

White spots on the skin can occur with many different conditions, including eczema. Depending on the cause, treatment may include topical products and medications. White skin spots aren’t ...

Thin skin is a result of thinning of the outermost layer of the skin, called the epidermis. It is most common in older adults. Thin skin is usually most visible on the face, arms, and hands. A person ...

Redeem V-Bucks by Feb 15 for free Color Splash Jellie skin in Fortnite, with LEGO versions available. However, it is worth noting that it does not apply to V-Bucks purchased directly through ...

Many people want clear skin, but it isn't always genetic. Sometimes, it's thanks to a good skincare routine. Research has shown that maintaining a skincare routine can improve the condition of ...

Subcutaneous: beneath the skin. As of Dec. 27, 2024, the FDA approved subcutaneous — or under the skin — Opdivo for patients with a wide range of solid tumors. This includes renal cell carcinoma [RCC] ...